Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
SSAAW was delisted on the 12th of December, 2022.
0 hedge funds and large institutions have $0 invested in Science Strategic Acquisition Corp. Alpha Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.
100% less funds holding
Funds holding: 62 → 0 (-62)
100% less capital invested
Capital invested by funds: $3.36M → $0 (-$3.36M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 60
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.75M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$986K |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$329K |
| 4 |
SCM
Saba Capital Management
New York
|
-$47K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$20K |
SSAAW Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) for Q4 2022, worth a combined $0 — down 100% from $3.36M a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of SSAAW and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.75M sold.
- 0 institutional investors held Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) as of Q4 2022, down from 62 in Q3 2022.
- Funds reported $0 of Science Strategic Acquisition Corp. Alpha Warrant stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Science Strategic Acquisition Corp. Alpha Warrant positions in Q4 2022 and 60 closed out, a net change of -60 holders.
- The largest Science Strategic Acquisition Corp. Alpha Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $1.75M sold.
Based on aggregated 13F filings for Q4 2022.